Uterine fibroids are common benign neoplasms, with a higher prevalence in older women
and in those of African descent. Many are discovered incidentally on clinical examination or …

In the treatment of women with abnormal uterine bleeding, once a thorough history, physical
examination, and indicated imaging studies are performed and all significant structural …

Simple Summary The most common therapies for severe and recurrent gynecological
cancers are hormone therapy and chemotherapy, and responsiveness to therapy is a key …

Uterine fibroids (leiomyomas or myomas), benign monoclonal tumors, are the most common
benign tumors in women. Heavy or prolonged menstrual bleeding, abnormal uterine …

Uterine fibroids are the most common gynecological disorder, classically requiring surgery
when symptomatic. Although attempts at finding a nonsurgical cure date back to centuries, it …

Objective To investigate the efficacy and safety of the oral gonadotropin-releasing hormone
receptor antagonist, relugolix, in patients experiencing uterine fibroid–associated pain …

The recent shift in focus from hormones to fibroid stem cells and genetic aberrations should
lead not only to a deeper understanding of the specific cause of fibroids, but also to the …

Uterine fibroids (UFs), leiomyomas or myomas, are a type of malignancy that affects the
smooth muscle of the uterus, and it is most commonly detected in women of reproductive …

Uterine fibroids (leiomyomas) are the most common benign neoplasm of the female pelvis
and have a lifetime prevalence exceeding 80% among African American women and …

Myomas, also known as fibroids, are a specific characteristic of the human species. No other
primates develop fibroids. At a cellular level, myomas are benign hyperplastic lesions of …